Lombardia
In Lombardy region 67,2% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 155 cases of cervicocarcinoma and 65 related deaths and thus results to be c...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SEEd Medical Publishers
2008-09-01
|
| Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
| Subjects: | |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1001 |
| Summary: | In Lombardy region 67,2% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 155 cases of cervicocarcinoma and 65 related deaths and thus results to be cost-effective (27.092 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 142 cancer cases and 61 deaths could be prevented, with a very similar cost-effectiveness ratio. In Lombardy region, the net cost for woman vaccinated is 197 € for the single cohort and 199 € for the multiple cohort. |
|---|---|
| ISSN: | 2240-256X |